Jim Simons Orgenesis Inc. Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Orgenesis Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 29,499 shares of ORGS stock, worth $156,344. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,499

Previous 34,599 14.74%

Holding current value

$156,344

Previous $28,000 39.29%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$0.39 - $0.63 $1,989 - $3,213	-5,100 Reduced 14.74%	29,499 $17,000
Q1 2024 May 13, 2024	SELL	$0.28 - $0.9 $1,176 - $3,780	-4,200 Reduced 10.83%	34,599 $28,000
Q4 2023 Feb 13, 2024	SELL	$0.44 - $0.96 $2,114 - $4,612	-4,805 Reduced 11.02%	38,799 $19,000
Q3 2023 Nov 14, 2023	SELL	$0.41 - $1.4 $940 - $3,213	-2,295 Reduced 5.0%	43,604 $27,000
Q2 2023 Aug 11, 2023	SELL	$1.01 - $1.44 $303 - $432	-300 Reduced 0.65%	45,899 $64,000
Q1 2023 May 12, 2023	SELL	$1.18 - $2.59 $1,534 - $3,367	-1,300 Reduced 2.74%	46,199 $55,000
Q4 2022 Feb 13, 2023	SELL	$1.18 - $2.24 $4,130 - $7,840	-3,500 Reduced 6.86%	47,499 $93,000
Q3 2022 Nov 14, 2022	SELL	$1.38 - $2.38 $7,313 - $12,614	-5,300 Reduced 9.41%	50,999 $72,000
Q2 2022 Aug 12, 2022	SELL	$1.8 - $3.74 $2,520 - $5,236	-1,400 Reduced 2.43%	56,299 $136,000
Q1 2022 May 13, 2022	SELL	$2.31 - $3.72 $13,860 - $22,320	-6,000 Reduced 9.42%	57,699 $200,000
Q4 2021 Feb 11, 2022	SELL	$2.61 - $4.9 $33,930 - $63,700	-13,000 Reduced 16.95%	63,699 $183,000
Q3 2021 Nov 12, 2021	SELL	$4.6 - $5.44 $169,740 - $200,736	-36,900 Reduced 32.48%	76,699 $380,000
Q2 2021 Aug 13, 2021	SELL	$4.19 - $5.88 $663,482 - $931,092	-158,349 Reduced 58.23%	113,599 $576,000
Q1 2021 May 13, 2021	SELL	$4.77 - $8.08 $40,311 - $68,284	-8,451 Reduced 3.01%	271,948 $1.56 Million
Q4 2020 Feb 10, 2021	BUY	$4.4 - $5.63 $186,560 - $238,712	42,400 Added 17.82%	280,399 $1.26 Million
Q3 2020 Nov 13, 2020	BUY	$4.75 - $5.99 $434,150 - $547,486	91,400 Added 62.35%	237,999 $1.2 Million
Q2 2020 Aug 13, 2020	BUY	$3.6 - $7.84 $393,480 - $856,912	109,300 Added 293.04%	146,599 $891,000
Q1 2020 May 14, 2020	BUY	$2.76 - $5.44 $63,755 - $125,664	23,100 Added 162.69%	37,299 $142,000
Q4 2019 Feb 13, 2020	BUY	$2.6 - $4.66 $36,917 - $66,167	14,199 New	14,199 $66,000

Others Institutions Holding ORGS

# of Institutions

Shares Held

1.61M

Call Options Held

Put Options Held

View Full List

About Orgenesis Inc.

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $135M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

More about ORGS

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account